Back to Authors

Sica, Giacomo

https://orcid.org/0000-0002-9518-9744

Mayo Clinic

Boston University

Citations 2

Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb
Napoli, Claudio , Williams‐Ignarro, Sharon, Nigris, Filomena de , Rosa, Gaetano De , Lerman, Lilach O. , Farzati, Bartolomeo, Matarazzo, A, Sica, Giacomo , Botti, Chiara, Fiore, Andrea, Byrns, Russell E., Sumi, Daigo , Sica, Vincenzo, Ignarro, Louis J.

Proceedings of the National Academy of Sciences | November 14, 2005 | Volume: 102 | Issue: 47 | Pages: 17202-17206

10.1073/pnas.0508534102 Get It

Lower-limb ischemia is a major health problem. Because of the absence of effective treatment in the advanced stages of the disease, amputation is undertaken to alleviate unbearable symptoms. Novel therapeutic approaches include the intramuscular use of autologous bone marrow cells (BMCs). Because tissue ischemia is associated with an overwhelming generation of oxygen radicals and negative effects due to perturbed shear-stress, metabolic intervention with antioxidants and l -arginine could potentially induce beneficial effects beyond those achieved by BMCs. The protective effect of autologous BMCs and vascular protection by metabolic cotreatment (1.0% vitamin E added to the chow and 0.05% vitamin C and 6% l -arginine added to the drinking water) were examined in ischemia-induced angiogenesis in the mouse hindlimb, a model of extensive acute peripheral arterial occlusion. i.v. BMC therapy improved blood flow and increased capillary densities and expression of Ki-67, a proliferation-associated protein. This beneficial effect was amplified by metabolic cotreatment, an intervention inducing vascular protection, at least in part, through the nitric oxide pathway, reduction of systemic oxidative stress, and macrophage activation. Therefore, although a cautious approach is mandatory when experimental findings are extended to human diseases, autologous BMCs together with metabolic intervention could be an effective clinical treatment for peripheral arterial disease.
Beneficial effects of antioxidants and l -arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress
Nigris, Filomena de , Lerman, Lilach O. , Ignarro, Sharon Williams, Sica, Giacomo , Palinski, Wulf , Ignarro, Louis J., Napoli, Claudio , Lerman, Amir

Proceedings of the National Academy of Sciences | February 4, 2003 | Volume: 100 | Issue: 3 | Pages: 1420-1425

10.1073/pnas.0237367100 Get It

Atherogenesis is enhanced in arterial segments exposed to disturbed blood flow, indicating the active participation of the hemodynamic environment in lesion formation. Turbulent shear stress selectively regulates responsive genes in the endothelium and increases the damage induced by free radicals. The purpose of the present study was to evaluate the effects of intervention with antioxidants and l -arginine on endothelial NO synthase (eNOS) and oxidation-sensitive gene perturbation induced by disturbed flow in vitro and in vivo . Both human endothelial cells exposed to shear stress and high atherosclerosis-prone areas of hypercholesterolemic low-density lipoprotein receptor knockout (LDLR −/− ) mice showed increased activities of redox-transcription factors (ELK-1, p -Jun, and p -CREB) and decreased expression of eNOS. Intervention with antioxidants and l -arginine reduced the activation of redox-transcription factors and increased eNOS expression in cells and in vivo . These results demonstrate that atherogenic effects induced by turbulent shear stress can be prevented by cotreatment with antioxidants and l -arginine. The therapeutic possibility to modulate shear stress-response genes may have important implications for the prevention of atherosclerosis and its clinical manifestations.